170 related articles for article (PubMed ID: 8339286)
21. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Morecki S; Slavin S
Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
23. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Myklebust AT; Godal A; Juell S; Pharo A; Fodstad O
Cancer Res; 1994 Jan; 54(1):209-14. PubMed ID: 7505198
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Dec; 5 Suppl 1():33-9. PubMed ID: 8853522
[TBL] [Abstract][Full Text] [Related]
26. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Wu A; Mazumder A; Martuza RL; Liu X; Thein M; Meehan KR; Rabkin SD
Cancer Res; 2001 Apr; 61(7):3009-15. PubMed ID: 11306480
[TBL] [Abstract][Full Text] [Related]
27. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
28. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
Zhou X; Lu X; Arthur G
Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
[TBL] [Abstract][Full Text] [Related]
29. Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
Feller N; Jansen-van der Weide MC; van der Pol MA; Westra GA; Ossenkoppele GJ; Schuurhuis GJ
Exp Hematol; 2005 Jan; 33(1):120-30. PubMed ID: 15661405
[TBL] [Abstract][Full Text] [Related]
30. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
31. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
32. Cryopreservation of human bone marrow after purging T-cells or tumor cells.
Zhang ZX; Xu YJ; Chen Y; Li Y; Shen BF; Bai Y
Cryobiology; 1994 Oct; 31(5):478-82. PubMed ID: 7988157
[TBL] [Abstract][Full Text] [Related]
33. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
34. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
35. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG
Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774
[TBL] [Abstract][Full Text] [Related]
36. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
[TBL] [Abstract][Full Text] [Related]
37. [Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro].
Hu ZP; Liu WL; Stuart B; Zhang YC
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):621-3. PubMed ID: 18246821
[TBL] [Abstract][Full Text] [Related]
38. Long-term cryopreservation of bone marrow for autologous transplantation.
Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
[TBL] [Abstract][Full Text] [Related]
39. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
40. [Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells].
Hrkal Z; Grebenová D; Cajthamlová H; Soucek J; Bartosová J; Fuchs O; Marinov I; Kobylka P; Klamová H; Sponerová D
Cas Lek Cesk; 2002 Sep; 141 Suppl():41-6. PubMed ID: 12428422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
